Principal investigator: Yuan Guoqiang
Coronary heart diseaseArrhythmiaChronic heart failure
The Department of Cardiovascular Diseases is a National Health Commission Key Clinical Specialty in TCM and the only national key clinical specialty in TCM cardiovascular medicine in Hebei Province. It is also a National Regional Diagnosis and Treatment Center, the Collateral Disease Key Research Laboratory of the State Administration of TCM (and a construction unit of its Collateral Disease Key Discipline), and a diagnosis and treatment base of Beijing Fuwai Hospital.
The department was founded by Professor Wu Yiling, a well-known TCM cardiovascular expert and Academician of the Chinese Academy of Engineering. It integrates clinical care, research and teaching, and is a core department of the hospital with integrated Chinese and Western medicine features.
Guided by TCM collateral theory, the department has systematically studied the pathogenesis of coronary heart disease, arrhythmia and chronic heart failure. It develops treatment methods and effective formulas from this new perspective and uses its own collateral-regulating drugs to build systematic treatment plans for cardiovascular disease, with an integrated approach to vascular lesions as a key feature. Its findings include:
- Coronary heart disease: its methods and drugs can significantly stabilize vulnerable plaques, reduce the rate of cardiovascular events and improve long-term outcomes for patients with acute myocardial infarction who undergo interventional treatment.
- Arrhythmia: it can effectively treat premature beats and atrial fibrillation and significantly increase heart rate in patients with slow arrhythmia, and provides drug options for slow arrhythmia with premature beats and for heart insufficiency with arrhythmia.
- Chronic heart failure: its collateral-regulating drugs can improve both clinical symptoms and prognosis.
About the principal investigator: Yuan Guoqiang
Research and awards: core member of several national and provincial projects, including national 973 and 863 programs, 11th and 12th Five-Year Plan major science programs and National Natural Science Foundation grants. Prizes include 3 first prizes for Science and Technology Progress (China Association of Chinese Medicine), 1 first prize for academic writing, 1 first prize and 1 third prize for Science and Technology Progress (Hebei Province), 2 first prizes for Science and Technology (Hebei Association of Chinese Medicine) and 1 first prize (Shijiazhuang). Author of over 50 papers in SCI and Chinese core journals, holder of 1 national invention patent and contributor to 8 monographs including Theory of Collaterals. Second tier of Hebei's "333 Talent Project" and a Shijiazhuang Municipal Top Talent.
Expertise: integrated Chinese and Western treatment of angina pectoris, acute myocardial infarction, arrhythmias, heart failure, hypertension, hyperlipidemia and cardiomyopathy; skilled in coronary angiography, stent implantation and managing related complications.
Yuan Guoqiang
Chief TCM Physician · Master's Supervisor
Director of Cardiovascular Ward 1, Hebei Yiling Hospital; trained under Academician Wu Yiling.
- Standing committee member, Collateral Disease Branch, China Association of Chinese Medicine
- Council member (2nd Council), Collateral Disease Professional Committee, World Federation of Chinese Medicine Societies
- Standing committee member, Collateral Disease Branch, Hebei Association of Integrated Chinese and Western Medicine
- Standing committee member, 2nd Cerebrovascular and Cardiovascular Disease Professional Committee, Hebei Association of Chinese Medicine
Planning a clinical trial with us?
Contact the Drug Clinical Trial Institution Office, 4th floor, Outpatient Building, 385 Xinshi North Road, Shijiazhuang. Reception hours: weekdays 8:30–11:30 and 14:00–17:00.